MAP1LC3B and neoplasm: Interrogation of a TCGA dataset led to the conclusion that patients bearing a tumor with low expression of such Hh/EMT genes along with high expression of the MAP1LC3B gene (suggestive of active autophagy) have a better overall survival and are more responsive to platinum-based therapy.